Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Biomedical Reports|June 16, 2023
Programmed death‑ligand 1 expression in tumor cells and tumor‑infiltrating lymphocytes are associated with depth of tumor invasion in penile cancerSakkarn Sangkhamanon, Natcha Kotano, Wichien Sirithanaphol, et al.Current Medical Research and Opinion|June 17, 2020
Palbociclib and beyond for the treatment of HR + HER2- metastatic breast cancer: an Asian-Pacific perspective and practical management guide on the use of CDK4/6 inhibitorsShaheenah Dawood, Joanne Wing-Yan Chiu, Chiun-Sheng Huang, et al.Anticancer Research|December 16, 2014
Melatonin in patients with cancer receiving chemotherapy: a randomized, double-blind, placebo-controlled trialAumkhae Sookprasert, Nutjaree Pratheepawanit Johns, Anakapong Phunmanee, et al.Asian Pacific Journal of Cancer Prevention : APJCP|March 14, 2013
Evaluation of efficacy, safety and tolerability of high dose-intermittent calcitriol supplementation to advanced intrahepatic cholangiocarcinoma patients--a pilot studyAumkhae Sookprasert, Ake Pugkhem, Narong Khuntikeo, et al.Journal of Epidemiology|May 16, 2018
Breast Cancer Incidence Trends and Projections in Northeastern ThailandShama Virani, Jarin Chindaprasirt, Kosin Wirasorn, et al.The Oncologist|July 7, 2025
Immune-mediated adverse events in the randomized phase 3 TOPAZ-1 study of durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancerLorenzo Antonuzzo, Hidenori Takahashi, Joon Oh Park, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2021
Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer-Results from Phase Ib Trial IMU.ACS.001Ursula Wiedermann, Erika Garner-Spitzer, Yee Chao, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 17, 2025
FGFR2 Fusions or Rearrangements in Young Intrahepatic and Perihilar Cholangiocarcinoma Patients: Key Genetic Insights From a Pan-Asian StudyYuta Maruki, Yasushi Yatabe, Chiharu Mizoguchi, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 25, 2025
Trastuzumab Deruxtecan in Patients with HER2-Overexpressing Non-Small Cell Lung Cancer: Results From Part 1 of the Open-label, Multicenter, Phase 1b DESTINY-Lung03 TrialDavid Planchard, Hye Ryun Kim, Thatthan Suksombooncharoen, et al.Pageof 4